Pulike Biological Engineering (603566) — Capital Reinvestment Ratio
Pulike Biological Engineering (603566) has a Capital Reinvestment Ratio of 0.18x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥87.38 Million) in capital expenditures (CN¥15.63 Million). Check 603566 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pulike Biological Engineering Capital Reinvestment Ratio (2010–2024)
This chart tracks Pulike Biological Engineering's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see Pulike Biological Engineering operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Pulike Biological Engineering (2010–2024)
Year-by-year Capital Reinvestment Ratio for Pulike Biological Engineering from 2010 to 2024. See how much free cash does Pulike Biological Engineering generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | CN¥268.79 Million | CN¥121.06 Million | ▼ -58.2% |
| 2023 | 1.08x | CN¥282.78 Million | CN¥304.98 Million | ▼ -31.0% |
| 2022 | 1.56x | CN¥228.36 Million | CN¥356.76 Million | ▲ +4.6% |
| 2021 | 1.49x | CN¥212.53 Million | CN¥317.54 Million | ▲ +120.8% |
| 2020 | 0.68x | CN¥261.83 Million | CN¥177.14 Million | ▲ +11.3% |
| 2019 | 0.61x | CN¥140.10 Million | CN¥85.18 Million | ▲ +43.2% |
| 2018 | 0.42x | CN¥126.27 Million | CN¥53.62 Million | ▲ +0.9% |
| 2017 | 0.42x | CN¥140.86 Million | CN¥59.29 Million | ▲ +44.3% |
| 2016 | 0.29x | CN¥253.03 Million | CN¥73.79 Million | ▼ -57.3% |
| 2015 | 0.68x | CN¥187.09 Million | CN¥127.84 Million | ▲ +60.3% |
| 2014 | 0.43x | CN¥151.21 Million | CN¥64.47 Million | ▼ -32.3% |
| 2013 | 0.63x | CN¥181.21 Million | CN¥114.19 Million | ▲ +8.2% |
| 2012 | 0.58x | CN¥147.96 Million | CN¥86.20 Million | ▲ +39.4% |
| 2011 | 0.42x | CN¥152.54 Million | CN¥63.73 Million | ▼ -38.0% |
| 2010 | 0.67x | CN¥70.98 Million | CN¥47.80 Million | — |